Pharma
Stay updated with the latest happenings in the pharmaceutical industry. Get insights into drug development, innovations, regulatory updates, and emerging trends. Discover the advancements shaping the future of healthcare. Explore the world of pharma with our comprehensive coverage at Pharmtales.com.
2seventy Bio slashes 176 jobs and looks for new CEO after cell therapy setback
2seventy bio, the spinoff from bluebird bio, is undergoing significant changes under the leadership of CEO Nick Leschly. The company ...
Vertex partners with Septerna to develop GPCR-targeting drugs for rare diseases
Septerna, a biotech company, has secured an additional $47.5 million in funding through a licensing agreement with Vertex, a prominent ...
Arbutus scraps COVID-19 and RNA degradation programs after disappointing preclinical results
Arbutus Biopharma has made significant strategic shifts by discontinuing its involvement in COVID-19 research and RNA destabilizer programs, redirecting its ...
Acelyrin’s lead drug flops in phase 3 trial, wiping out half of its market value
Acelyrin, a biotech company based in Los Angeles, has delivered a shocking blow to its investors. Despite successfully raising an ...
Tagrisso-chemo combo delays EGFR NSCLC progression by 9 months in first-line (IASLC WCLC 2023 Conference)
Against the formidable challenge of non-small cell lung cancer (NSCLC), AstraZeneca’s Tagrisso (osimertinib), when partnered with chemotherapy, has unveiled remarkable ...
Fasenra, a new treatment for EGPA, achieved remission in Phase III trial (IASLC WCLC 2023 Conference)
The MANDARA Phase III trial has shed new light on the effectiveness of AstraZeneca’s Fasenra (benralizumab). Unveiling favorable high-tier outcomes, ...
New drug Enhertu shows promise for HER2-mutant lung cancer patients (IASLC WCLC 2023 Conference)
The International Association for the Study of Lung Cancer (IASLC) presented pivotal results from the DESTINY-Lung02 Phase II trial at ...
FDA approves Aphexda for stem cell mobilization in multiple myeloma
After a decade of limited progress, the FDA has granted approval for the use of BioLineRx’s motixafortide, also known as ...
FDA doubts Onpattro’s benefit in heart disease, Alnylam faces Pfizer hurdle
The FDA has raised significant concerns about Alnylam’s attempt to expand the use of Onpattro for the treatment of transthyretin ...
Sandoz to market Samsung Bioepis’ biosimilar of Stelara in US and Canada
Sandoz is expanding its biosimilar portfolio by signing a commercialization agreement with Samsung Bioepis for a biosimilar version of Johnson ...
Walgreens to pay $44 million to customers who bought faulty Theranos blood tests
Walgreens has reached a settlement in a long-running class-action case related to patients who underwent fraudulent blood tests provided by ...
Merck showcases new data on sotatercept for PAH, awaits FDA decision
Merck & Co. has unveiled new clinical data on sotatercept, reinforcing the drug candidate’s safety and efficacy in the treatment ...
BMS scores another phase 2 win for its pulmonary fibrosis drug
Bristol Myers Squibb (BMS) is making significant strides in the field of pulmonary fibrosis treatment, particularly with its lysophosphatidic acid ...
Moderna expands cancer vaccine portfolio with Immatics deal worth up to $1.7B
Moderna is intensifying its focus on cancer vaccines and cell therapies through a newly announced research partnership with Immatics, a ...
Novartis drops Gyroscope’s gene therapy for eye disease after disappointing trial results
Novartis is in the process of divesting its eye disease unit, a move that includes discontinuing a geographic atrophy (GA) ...
Novo Nordisk’s Wegovy boosts heart health, J.P. Morgan predicts $71B GLP-1 market by 2032
The demand for Novo Nordisk’s obesity medications is surging, with production capacity being the primary limiting factor in the short ...
Nurix and Seagen Join Forces to Pioneer Cancer Therapies by Combining Protein Degradation and ADC Technologies
Seagen has just sealed a strategic partnership with Nurix Therapeutics, headquartered in San Francisco. This collaboration is poised to unlock ...
Amgen Unveils Exciting First-Line KRAS G12C NSCLC Data: Lumakras (Sotorasib) with Chemotherapy Shines at WCLC
Amgen has unveiled exciting findings from a segment of the CodeBreaK 101 clinical trial, a Phase 1b study investigating the ...
Datopotamab Deruxtecan + Imfinzi Transform First-Line NSCLC Treatment in TROPION-Lung04 Trial
The TROPION-Lung04 Phase Ib trial has unveiled highly promising results. The trial showcases the potential of datopotamab deruxtecan (Dato-DXd), in ...
Wilms Tumor: What You Need to Know
Let’s discuss about Wilms Tumor. You may wonder what causes this rare disease, how it is diagnosed and treated, and ...
Eli Lilly’s Mounjaro gets NICE approval for type 2 diabetes after cost-effectiveness review
Eli Lilly’s diabetes medication, Mounjaro (tirzepatide), has been on a winning streak since its US launch in May, and now ...
BMS faces lawsuit for allegedly extending Pomalyst monopoly with fraudulent patents and payoffs
Bristol Myers Squibb (BMS) and Celgene’s widely-used multiple myeloma treatment, Pomalyst, has found itself entangled in a legal battle after ...
Roche’s subcutaneous Tecentriq faces FDA setback due to manufacturing updates
Roche may experience a delay in the FDA decision for its subcutaneous version of the cancer immunotherapy Tecentriq, as it ...
Pfizer CEO supports migraine sufferers and urges employers to do the same
Pfizer’s CEO, Dr. Albert Bourla, is championing a disease awareness campaign by leveraging his social media platforms to underscore the ...
AstraZeneca and Verge partner to discover AI-driven drugs for rare neurodegenerative diseases
Verge Genomics is expanding its roster of Big Pharma partnerships by teaming up with AstraZeneca in a substantial $42 million ...
Asensus and Nvidia team up to boost AI-powered digital surgery solutions
Asensus Surgical, despite having secured approvals for its robotic and AI tools, is not resting on its laurels. The company ...
Ibex raises $55M to expand its AI-powered cancer diagnostics in the US and beyond
Ibex Medical Analytics, an Israeli startup specializing in Artificial intelligence-powered cancer diagnostics, has secured an impressive $55 million in funding ...
ILiAD’s nasal vaccine prevents whooping cough infection in phase 2b trial
ILiAD Biotechnologies, a Florida-based biotech company, is celebrating a significant milestone in the development of its whooping cough vaccine. In ...
Otsuka and Shape Therapeutics join forces to create gene therapies for eye diseases using AI-powered platform
Just a week after Otsuka Pharmaceutical ventured into the psychedelics sector, the Japanese pharmaceutical giant has struck a collaboration deal ...
J&J’s Rybrevant Beats Chemo In Lung Cancer Patients Who Failed Tagrisso
The medical community buzzed with anticipation when Johnson & Johnson (J&J) released information about Rybrevant, their latest drug venture into ...
